The major reason why the said letter has gained much attention from different quarters is that it was from the office of Dr. Terrence L. Boos who is the Section Chief of the Drug and Chemical Evaluation Section. The section is under the Office of Diversion Control in the DEA and this particular letter was written to the Executive Secretary of the Board of Pharmacy of Alabama who requested a control status update on delta-8 THC. This means the contents of the letter can easily be used to juxtapose the current stand of the DEA as it applies to substance control for delta-8 THC.
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…
In 1968, a few joints I gave away left me facing the possibility of decades…
Here's the part that should worry every operator, investor, and vendor in the industry: this…
For one hash maker the clock starts at harvest, and the flower is in the…
Cannabis can absolutely take you somewhere that looks like a classic psychedelic experience. It just…
Researchers analyzing two ancient skeletons from Indonesia found dramatic dental wear and traces of arecoline,…